Synopsis
Over the past 5 years, HLTH has emerged as the preeminent event in the healthcare industry. We are delighted that Emulate Chief Scientific Officer Lorna Ewart has been invited to participate in a panel discussion focused on increasing cost effectiveness within the drug development process. Alex Morgan from Khosla Ventures will be moderating this exciting point/counter-point discussion.
Register now, and stay tuned for more details on the agenda!
Register